| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444454 | European Journal of Cancer | 2013 | 7 Pages |
Abstract
Overall, this study suggests that starting with less toxic first-line treatment is a valid option since it does not exert a deleterious effect on the risk of overall progression or death.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J. Pénichoux, S. Michiels, O. Bouché, P.-L. Etienne, P. Texereau, D. Auby, P. Rougier, M. Ducreux, J.-P. Pignon,